标题
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
作者
关键词
-
出版物
Pharmaceuticals
Volume 14, Issue 3, Pages 280
出版商
MDPI AG
发表日期
2021-03-22
DOI
10.3390/ph14030280
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance
- (2021) Javier Martinez-Useros et al. Cancers
- Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
- (2020) Eric S Christenson et al. LANCET ONCOLOGY
- Repurposing drugs in oncology: From candidate selection to clinical adoption
- (2020) Pan Pantziarka et al. SEMINARS IN CANCER BIOLOGY
- Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells
- (2020) Serena Veschi et al. Scientific Reports
- Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer
- (2020) Michael Overman et al. Journal for ImmunoTherapy of Cancer
- Global Burden of 5 Major Types Of Gastrointestinal Cancer
- (2020) Melina Arnold et al. GASTROENTEROLOGY
- Targeting MerTK Enhances Adaptive Immune Responses After Radiation Therapy
- (2020) Garth W. Tormoen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
- (2020) Kousik Kesh et al. Microbial Cell Factories
- The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
- (2020) Won Jin Ho et al. Nature Reviews Clinical Oncology
- Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
- (2020) Wenjie Yang et al. Annals of Translational Medicine
- Repurposing old drugs to fight multidrug resistant cancers
- (2020) Jelena Dinić et al. DRUG RESISTANCE UPDATES
- Recycling the Purpose of Old Drugs to Treat Ovarian Cancer
- (2020) Mariana Nunes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of bacterial contamination in bile on pancreatic cancer cell survival
- (2020) Hannah R. Shrader et al. SURGERY
- Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway
- (2020) Tao Li et al. ONCOLOGY REPORTS
- The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma
- (2020) Sona Ciernikova et al. Biomedicines
- Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine
- (2020) Cristina P.R. Xavier et al. CANCER LETTERS
- Cancer and the dopamine D2 receptor: a pharmacological perspective
- (2019) Jillian S Weissenrieder et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
- (2019) Janet E. Murphy et al. JAMA Oncology
- Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma
- (2019) Anne Wynn et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
- (2019) Sepideh Aminzadeh-Gohari et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Metformin Alters the Duodenal Microbiome and Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity
- (2019) Tien S Dong et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes
- (2019) Erick Riquelme et al. CELL
- The 2019 WHO classification of tumours of the digestive system
- (2019) Iris D. Nagtegaal et al. HISTOPATHOLOGY
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
- (2019) Melina Arnold et al. LANCET ONCOLOGY
- Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment
- (2019) Jingjing Lu et al. JOURNAL OF BIOMEDICAL OPTICS
- Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy
- (2019) Vikram Shaw et al. SEMINARS IN CANCER BIOLOGY
- Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma
- (2019) Can Huang et al. Cancers
- The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer
- (2019) Rosalba Florio et al. Cancers
- Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models
- (2018) Ryan M Thomas et al. CARCINOGENESIS
- Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
- (2018) Herbert Hurwitz et al. INVESTIGATIONAL NEW DRUGS
- Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling
- (2018) Wanxing Duan et al. ONCOLOGY REPORTS
- Itraconazole inhibits invasion and migration of pancreatic cancer cells by suppressing TGF-β/SMAD2/3 signaling
- (2018) Ke Chen et al. ONCOLOGY REPORTS
- The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
- (2018) Smruti Pushalkar et al. Cancer Discovery
- Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study
- (2018) Lei Huang et al. BMC Medicine
- Itraconazole inhibits proliferation of pancreatic cancer cells through activation of Bak-1
- (2018) Fan Jiang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
- (2018) Serena Veschi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway
- (2018) Xin Wang et al. Scientific Reports
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Current and future therapies for advanced pancreatic cancer
- (2017) Rohan Gupta et al. JOURNAL OF SURGICAL ONCOLOGY
- Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
- (2017) Ke Chen et al. Molecular Cancer
- Drug repurposing in cancer
- (2017) Linda Sleire et al. PHARMACOLOGICAL RESEARCH
- Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer
- (2017) Alok Ranjan et al. TUMOR BIOLOGY
- Repurposing itraconazole as an anticancer agent
- (2017) Hiroshi Tsubamoto et al. Oncology Letters
- Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
- (2017) Yi-Wei Dong et al. Oncotarget
- Liposomal irinotecan in gemcitabine-refractory metastatic pancreatic cancer: efficacy, safety and place in therapy
- (2017) Emma Kipps et al. Therapeutic Advances in Medical Oncology
- The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
- (2017) Xiaogang Li et al. Scientific Reports
- High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study
- (2017) Kishore Polireddy et al. Scientific Reports
- Disulfiram';s Anticancer Activity: Evidence and Mechanisms
- (2016) Yang Jiao et al. Anti-Cancer Agents in Medicinal Chemistry
- Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors
- (2016) Anthony J. O’Donoghue et al. BIOLOGICAL CHEMISTRY
- The cell-autonomous mechanisms underlying the activity of metformin as an anticancer drug
- (2016) Francesca Sacco et al. BRITISH JOURNAL OF CANCER
- Metformin and pancreatic cancer: Is there a role?
- (2016) Andre De Souza et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methylation
- (2016) Qian Xiao et al. CANCER RESEARCH
- Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice
- (2016) Pouria Jandaghi et al. GASTROENTEROLOGY
- Pancreatic Cancer
- (2016) Cinthya S. Yabar et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study
- (2016) Xiaozhou Fan et al. GUT
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy
- (2016) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns
- (2016) Faiyaz Notta et al. NATURE
- The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
- (2016) Osama Al-Assar et al. RADIOTHERAPY AND ONCOLOGY
- ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
- (2016) James M. Wilson et al. RADIOTHERAPY AND ONCOLOGY
- Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis
- (2016) Alok Ranjan et al. Scientific Reports
- A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
- (2015) G. Deplanque et al. ANNALS OF ONCOLOGY
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma
- (2015) D. Masso-Valles et al. CANCER RESEARCH
- Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis
- (2015) Amanda Kirane et al. CANCER RESEARCH
- Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer
- (2015) C. J. Whatcott et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor
- (2015) A. Sebio et al. CLINICAL CANCER RESEARCH
- A rapidin vivoscreen for pancreatic ductal adenocarcinoma therapeutics
- (2015) Ozhan Ocal et al. Disease Models & Mechanisms
- Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
- (2015) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
- (2015) Sil Kordes et al. LANCET ONCOLOGY
- Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer
- (2015) Wenwen Chien et al. Molecular Oncology
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
- (2015) A. J. Gunderson et al. Cancer Discovery
- Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
- (2015) Rebecca Lamb et al. Oncotarget
- Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis
- (2015) Yixiang Mao et al. Scientific Reports
- Itraconazole therapy in a pancreatic adenocarcinoma patient: A case report
- (2015) Nicholas R Lockhart et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines
- (2015) Jonathan P. Celli et al. LASERS IN SURGERY AND MEDICINE
- Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer
- (2014) M T Huggett et al. BRITISH JOURNAL OF CANCER
- Endosymbiotic theory for organelle origins
- (2014) Verena Zimorski et al. CURRENT OPINION IN MICROBIOLOGY
- Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
- (2014) Joong Sup Shim et al. International Journal of Biological Sciences
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus
- (2014) Antonella Napolitano et al. PLoS One
- Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments
- (2014) Irene Esposito WORLD JOURNAL OF GASTROENTEROLOGY
- Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells
- (2014) ITASU NINOMIYA et al. Oncology Letters
- Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations
- (2014) A. Yang et al. Cancer Discovery
- Pirfenidone Inhibits Pancreatic Cancer Desmoplasia by Regulating Stellate Cells
- (2013) S. Kozono et al. CANCER RESEARCH
- Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer
- (2013) Philippe Rougier et al. EUROPEAN JOURNAL OF CANCER
- An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
- (2013) Na-Ri Shin et al. GUT
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
- (2012) A. Gonçalves et al. ANNALS OF ONCOLOGY
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
- (2012) Matthew H. G. Katz et al. CANCER
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
- (2012) Freddie Bray et al. LANCET ONCOLOGY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Pancreatic cancers require autophagy for tumor growth
- (2011) S. Yang et al. GENES & DEVELOPMENT
- Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer
- (2011) Eric J. Duell MOLECULAR CARCINOGENESIS
- Precursor lesions in pancreatic cancer: morphological and molecular pathology
- (2011) Christopher J. Scarlett et al. PATHOLOGY
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP inhibitors: its role in treatment of cancer
- (2011) Alice Chen Chinese Journal of Cancer
- Stromal biology and therapy in pancreatic cancer
- (2010) A. Neesse et al. GUT
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Vitamin D for the prevention and treatment of pancreatic cancer
- (2009) Kun-Chun Chiang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Gemcitabine Plus Celecoxib in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma
- (2008) Tomislav Dragovich et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells
- (2008) A. Vonlaufen et al. CANCER RESEARCH
- Phase I Trial of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir and Chemoradiation for Locally Advanced Pancreatic Cancer
- (2008) Thomas B. Brunner et al. JOURNAL OF CLINICAL ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation